"Intuitive Surgical's Next-Gen da Vinci 5 Receives FDA Clearance for Advanced Robotic Surgery System"

Intuitive Surgical's stock surged after receiving FDA clearance for its next-generation robotic surgery system, da Vinci 5, which promises improved accuracy, precision, and computing power compared to its predecessor, da Vinci Xi. The company plans to initially launch the system for a small number of U.S. surgeons before a broader release, aiming to gather additional data on its use. CEO Gary Guthart anticipates that the new system will lead to better patient outcomes, enhanced experiences for both patients and care teams, and reduced overall healthcare costs.